Contract awardedPoint-of-care testing analysers and rapid tests

Genedrive supplies CYP2C19 point-of-care testing to LNWH

London North West University Healthcare NHS Trust is buying a point-of-care genetic testing service from Genedrive Diagnostics Ltd.

The test will quickly identify CYP2C19 variants linked to changes in how patients metabolise and respond to clopidogrel.

The trust awarded the £57,871 contract directly, without competition, in November 2026. It is due to end in November 2027.

Alert me to similar tenders

Contract ends November 2027

What
Point-of-care testing analysers and rapid tests
Value
£57,871
How it was bought
Below threshold - without competition
Dates and next
Dec 2026 to Nov 2027

How it was bought

1 official notice
  1. 4 Nov 2026Award noticeFind a Tender
  2. 1 Dec 2026Contract starts
  3. 30 Nov 2027Contract ends

How it compares

With every point-of-care testing analysers and rapid tests award since 2021

Half of awards fall between £41,984 and £1.06mMedian £180,000

Awards
277
Firms that won them
70
Median award
£180,000
of 255 with a value
This award
Smaller than 68%
of them
Typical length
1.5 years
In London
47 awards

Genedrive Diagnostics Ltd ranks 36th of 70 firms for point-of-care testing analysers and rapid tests awards since 2021.

RankFirmAwardsValue
1Locked28£137.3m
2Locked19£26.8m
3Locked15£1.4m
4Locked12£2.4bn
4Locked12£28.4m
6Locked11£21.7m
36Genedrive Diagnostics Ltd Won this one1£57,871
See who wins this work

Figures to 21 November 2026

Point-of-care testing analysers and rapid tests at other buyers

London North West University Healthcare NHS Trust has awarded 15 contracts since 2021.

  • Genedrive Diagnostics Ltd has won 1 public contract since 2021.

2 point-of-care testing analysers and rapid tests tenders are open now

See them
More point-of-care testing analysers and rapid tests contracts awarded in 2026